Related Experiment Videos
[Metastasizing malignant melanoma from unknown primary tumor]
1Hautklinik, am Klinikum Nürnberg.
Summary
Malignant melanoma with unknown primary site is rare (1.7%) and predominantly affects males. These patients have a poor prognosis, with a 5-year survival rate of only 14% after metastasis excision.
Area of Science:
- Oncology
- Dermatology
- Pathology
Context:
- Malignant melanoma is a serious skin cancer.
- Identifying the primary tumor site is crucial for treatment and prognosis.
- Unknown primary melanoma presents unique diagnostic challenges.
Purpose:
- To investigate the characteristics and outcomes of patients with malignant melanoma of unknown primary site.
- To analyze the metastatic patterns and survival rates in this patient cohort.
Summary:
- A study of 1426 melanoma patients found 24 (1.7%) with an unknown primary site, predominantly male.
- Metastases often occurred in lymph nodes, with some progressing to brain or skin.
- The 5-year survival rate after metastasis excision was a poor 14% in followed patients.
- Evidence of prior pigmented lesions and melanophages in scars was noted in some cases.
Impact:
- Highlights the poor prognosis associated with unknown primary malignant melanoma.
- Suggests potential diagnostic clues, such as previous skin lesions and melanophages.
- Emphasizes the need for continued research into the origins and management of such cases.